Tumor Cells-derived exosomal CircRNAs: Novel cancer drivers, molecular mechanisms, and clinical opportunities
A Vahabi, J Rezaie, M Hassanpour, Y Panahi… - Biochemical …, 2022 - Elsevier
Recently, circular RNAs (circRNAs) have appealed to a growing interest due to their
abundant expression and potential functions in cancer development. The most biological …
abundant expression and potential functions in cancer development. The most biological …
Targeting and engineering long non-coding RNAs for cancer therapy
RNA therapeutics (RNATx) aim to treat diseases, including cancer, by targeting or
employing RNA molecules for therapeutic purposes. Amongst the most promising targets …
employing RNA molecules for therapeutic purposes. Amongst the most promising targets …
The chromatin-associated RNAs in gene regulation and cancer
J Tang, X Wang, D Xiao, S Liu, Y Tao - Molecular Cancer, 2023 - Springer
Eukaryotic genomes are prevalently transcribed into many types of RNAs that translate into
proteins or execute gene regulatory functions. Many RNAs associate with chromatin directly …
proteins or execute gene regulatory functions. Many RNAs associate with chromatin directly …
Cancer-associated fibroblasts: an emerging target against esophageal squamous cell carcinoma
L Qiu, J Yue, L Ding, Z Yin, K Zhang, H Zhang - Cancer letters, 2022 - Elsevier
Esophageal squamous cell carcinoma (ESCC) is one of the most common human
malignancies worldwide and is associated with high morbidity and mortality. More than 70 …
malignancies worldwide and is associated with high morbidity and mortality. More than 70 …
LncRNA TMPO-AS1 promotes esophageal squamous cell carcinoma progression by forming biomolecular condensates with FUS and p300 to regulate TMPO …
XJ Luo, MM He, J Liu, JB Zheng, QN Wu… - … & molecular medicine, 2022 - nature.com
Esophageal squamous cell carcinoma (ESCC) is one of the most life-and health-threatening
malignant diseases worldwide, especially in China. Long noncoding RNAs (lncRNAs) have …
malignant diseases worldwide, especially in China. Long noncoding RNAs (lncRNAs) have …
Noncoding RNA mutations in cancer
H Zhou, X Hao, P Zhang, S He - Wiley Interdisciplinary Reviews …, 2023 - Wiley Online Library
Cancer is driven by both germline and somatic genetic changes. Efforts have been devoted
to characterizing essential genetic variations in cancer initiation and development. Most …
to characterizing essential genetic variations in cancer initiation and development. Most …
DNMT1 inhibition by pUG-fold quadruplex RNA
LI Jansson-Fritzberg, CI Sousa, MJ Smallegan… - RNA, 2023 - rnajournal.cshlp.org
Aberrant DNA methylation is one of the earliest hallmarks of cancer. DNMT1 is responsible
for methylating newly replicated DNA, but the precise regulation of DNMT1 to ensure faithful …
for methylating newly replicated DNA, but the precise regulation of DNMT1 to ensure faithful …
Circulating plasma exosomal long non-coding RNAs LINC00265, LINC00467, UCA1, and SNHG1 as biomarkers for diagnosis and treatment monitoring of acute …
Q Xiao, C Lin, M Peng, J Ren, Y Jing, L Lei… - Frontiers in …, 2022 - frontiersin.org
Exosomal long non-coding RNAs (lncRNAs) have emerged as a cell-free biomarker for
clinical evaluation of cancers. However, the potential clinical applications of exosomal …
clinical evaluation of cancers. However, the potential clinical applications of exosomal …
LncRNA CCAT1 participates in pancreatic ductal adenocarcinoma progression by forming a positive feedback loop with c-Myc
C Cheng, Z Liu, D Liu, H Chen, Y Wang… - Carcinogenesis, 2024 - academic.oup.com
Long noncoding RNAs (lncRNAs) play fundamental roles in cancer development; however,
the underlying mechanisms for a large proportion of lncRNAs in pancreatic ductal …
the underlying mechanisms for a large proportion of lncRNAs in pancreatic ductal …
Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma
Y Qin, D Zhang, H Zhang, L Hou, Z Wang, L Yang… - Cancer cell …, 2022 - Springer
Background Thyroid carcinoma (THCA) is the most common endocrine-related malignant
tumor. Despite the good prognosis, some THCA patients may deteriorate into more …
tumor. Despite the good prognosis, some THCA patients may deteriorate into more …